These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19172497)

  • 1. Treatment of elderly adults with acute promyelocytic leukemia: put the pedal to metal.
    Tallman MS
    Leuk Lymphoma; 2009 Jan; 50(1):12-3. PubMed ID: 19172497
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.
    McMullin MF; Nugent E; Thompson A; Hull D; Jones FG; Grimwade D
    Leukemia; 2005 Sep; 19(9):1676-7. PubMed ID: 16034463
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute promyelocytic leukemia in very elderly patients: still a clinical challenge.
    Forghieri F; Luppi M; Morselli M; Favale V; Potenza L; Volzone F; Maccaferri M; Torelli G
    Leuk Lymphoma; 2009 Jan; 50(1):119-21. PubMed ID: 19152166
    [No Abstract]   [Full Text] [Related]  

  • 4. [The biological characteristics and treatment of acute promyelocytic leukemia].
    Savchenko VG; Parovichnikova EN; Isaev VG; Demidova IA; Kuliev RG; Gribanova EO; Kliasova GA; Kucher RA; Sokolov AN; Momotiuk KS; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Budianskiĭ VM; Belousov EA; Lapin VA; Voloshin SV; Konstaninova TS; Filatov LB; Porokhina ON; Smirnova EA
    Ter Arkh; 1998; 70(7):5-11. PubMed ID: 9742627
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis.
    Zuberi L; Adeyinka A; Kuriakose P
    Cancer Genet Cytogenet; 2010 Apr; 198(2):170-2. PubMed ID: 20362234
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to therapy in acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; de Thé H
    N Engl J Med; 2014 Sep; 371(12):1170-2. PubMed ID: 25229938
    [No Abstract]   [Full Text] [Related]  

  • 7. Ring Chromosome 10 in a Case of Acute Promyelocytic Leukemia.
    Shehzad S; Nadeem M; Shan S; Shamsi TS
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):941-942. PubMed ID: 27981936
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia.
    Zhang X; Pan J
    Ann Hematol; 2017 Apr; 96(4):707-708. PubMed ID: 28154895
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute promyelocytic leukemia with tetraploid karyotype: first report in the Western hemisphere and update of previous reports.
    Ravella PM; Liu D; Kojima K; Weisberger J; Miura O; Kuyama J; Au W; Seiter K
    Leuk Res; 2011 Jun; 35(6):e93-5. PubMed ID: 21353702
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapy.
    Ravandi F
    Oncology (Williston Park); 2011 Jul; 25(8):741-3. PubMed ID: 21874836
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia.
    Young CS; Clarke KM; Mills KI
    EBioMedicine; 2015 Jun; 2(6):487-8. PubMed ID: 26288810
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel STAT5B-RARA fusion transcript in acute promyelocytic leukemia: identification and treatment response.
    Wang YY; Hao J; Liu ZY; Weng XQ; Sheng Y; Jiang CL; Zhu YM; Chen B; Xiong SM; Li JM; Chen QS; Chen HY; Qiao C; Chen Y
    Leuk Lymphoma; 2015; 56(9):2731-4. PubMed ID: 25629986
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.
    Fujisawa T; Takeda J; Aoki K; Ishikawa T
    Ann Hematol; 2014 Sep; 93(9):1621-3. PubMed ID: 24399307
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment for acute promyelocytic leukemia].
    Fujita H
    Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
    [No Abstract]   [Full Text] [Related]  

  • 15. Extramedullary disease in acute promyelocytic leukemia.
    Evans GD; Grimwade DJ
    Leuk Lymphoma; 1999 Apr; 33(3-4):219-29. PubMed ID: 10221502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute promyelocytic leukemia with t(15;17) and two previously unreported additional cytogenetic abnormalities.
    Rashidi A; Fisher SI
    Med Oncol; 2013 Mar; 30(1):392. PubMed ID: 23275121
    [No Abstract]   [Full Text] [Related]  

  • 17. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
    Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
    Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute promyelocytic leukemia, centre, experience, Turkey.
    Yildirim R; Gundogdu M; Ozbıcer A; Kiki I; Erdem F; Dogan H
    Transfus Apher Sci; 2013 Feb; 48(1):45-9. PubMed ID: 22892289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'standard of care' in acute promyelocytic leukemia.
    Warrell RP
    Leukemia; 1994; 8 Suppl 2():S56-8; discussion S62. PubMed ID: 7815838
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure.
    de Thé H; Pandolfi PP; Chen Z
    Cancer Cell; 2017 Nov; 32(5):552-560. PubMed ID: 29136503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.